EUVIMEDOpdag EUVIMED
LeserbriefFallbericht

Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report

Selcen Hoşgören-Tekin iD, Ahmet Atas iD, Dilek Seçkin iD, Ayşe Deniz Yücelten iD

International Journal of Dermatology · 2026-08-12

DOI: 10.1111/ijd.70632 ↗

At a glance

Leserbrief in International Journal of Dermatology, published online on 2026-08-12. Written by Selcen Hoşgören-Tekin and 3 co-authors. Institution: Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye. 5 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

Janus kinase inhibitorabrocitinibactinic prurigopediatric dermatologyphotodermatoses

Authors and institutions

  • Marmara Universitesi Tip Fakultesi, Istanbul, Türkiye.

ORCID profiles: Selcen Hoşgören-Tekin, Ahmet Atas, Dilek Seçkin, Ayşe Deniz Yücelten

Cite

APA

Hoşgören-Tekin, S., Atas, A., Seçkin, D., & Yücelten, A. D. (2026). Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. https://doi.org/10.1111/ijd.70632

Vancouver

Hoşgören-Tekin S, Atas A, Seçkin D, Yücelten AD. Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report. International Journal of Dermatology. 2026. doi:10.1111/ijd.70632

BibTeX
@article{HogrenTekin2026,
  author = {Hoşgören-Tekin, Selcen and Atas, Ahmet and Seçkin, Dilek and Yücelten, Ayşe Deniz},
  title = {Use of Abrocitinib in the Management of Treatment‐Resistant Actinic Prurigo: A Pediatric Case Report},
  journal = {International Journal of Dermatology},
  year = {2026},
  doi = {10.1111/ijd.70632}
}
Start for free →